Ac-DEVD-CHO - Caspase 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第1頁
Ac-DEVD-CHO - Caspase 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第2頁
Ac-DEVD-CHO - Caspase 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第3頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEAc-DEVD-CHOCat. No.: HY-P1001CAS No.: 169332-60-9分式: CHNO分量: 502.47Sequence: N-Acetyl-Asp-Glu-Val-Asp-alSequence Shortening: Ac-DEVD-al作靶點(diǎn): Caspase作通路: Apoptosis儲(chǔ)存式: Powder -80C 2 years-20C 1 yearIn solvent -80C 6 months-20C 1 m

2、onth溶解性數(shù)據(jù)體外實(shí)驗(yàn) H2O : 50 mg/mL (99.51 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 1.9902 mL 9.9508 mL 19.9017 mL5 mM 0.3980 mL 1.9902 mL 3.9803 mL10 mM 0.1990 mL 0.9951 mL 1.9902 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Ac-D

3、EVD-CHO種特異性 Caspase-3 抑制劑,Ki 值為 230 pM。IC50 & Target Caspase-1 Caspase-2 Caspase 3 Caspase-41/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE18 nM (Ki) 1710 nM (Ki) 0.23 nM (Ki) 132 nM (Ki)Caspase-5 Caspase-6 Caspase-7 Caspase-8205 nM (Ki) 31 nM (Ki) 1.6 nM (Ki) 0.92 nM (Ki)Caspase-9 Caspase-1060 nM

4、 (Ki) 12 nM (Ki)體外研究 To ascertain the role of caspase-3 in SLNT-induced apoptosis, a caspase-3 inhibitor (Ac-DEVD-CHO) isused. The addition of Ac-DEVD-CHO significantly prevents SLNT-induced apoptosis (from 32.911.21%decreases to 15.881.58% while NC and Ac-DEVD-CHO groups are 6.450.96%, 7.770.79%, r

5、espectively)2. The apoptosis rates of cells pretreated with zVAD-fmk (5.32%) or Ac-DEVD-CHO (7.43%) decreaseobviously after hypericin-mediated PDT treatment 3. Remarkably, 10 mol/L Ac-DEVD-CHO partially blocksthe effect of SIN-induced apoptosis and reduces the number of apoptotic nuclei. These effec

6、ts of SIN areblocked by the caspase-3 inhibitor Ac-DEVD-CHO. Camptothecin (4 M), a positive control, increasescaspase-3 activity, which is also blocked by Ac-DEVD-CHO 4.體內(nèi)研究 Compare with model group, in CI group, the concentrations of serum BUN are decreased significantly at alltime points after ope

7、ration and those of Cr are decreased significantly at 6 hours, then restored to those ofthe sham group at 12 hours and 24 hours; the concentrations of serum TNF-, IL-6 are decreased and thoseof IL-10 are elevated significantly at all time points. TNF- (g/L) 6 hours: 436.264.2 vs. 653.68.9, 12hours:

8、233.485.4 vs. 579.7137.1, 24 hours: 151.090.3 vs. 551.0119.8, IL-6 (g/L) 6 hours: 1033.2345.8vs. 1 595.3159.4, 12 hours: 366.368.3 vs. 1 330.7249.8, 24 hours: 241.2208.4 vs. 815.3572.7, IL-10 (g/L) 6 hours: 33.610.4 vs. 26.64.5, 12 hours: 37.25.0 vs. 24.54.3, 24 hours: 38.35.5 vs. 18.21.6, all P5.PR

9、OTOCOLCell Assay 4 OCLs are incubated with RANKL and treated with 0.5 mM SIN with or without the specific caspase-3 inhibitorAc-DEVD-CHO (10 M) for 24 h. At the end of the treatment, the cells are washed with PBS and are stainedfor 15 min with 10 M Hoechst 33258 dye. Images of the staineing cells ar

10、e captured with a fluorescentmicroscope. The differences are evaluated by counting the number of cells with apoptotic nuclearcondensation in each well 4.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal One hundred and two male mice are subjected t

11、o cecal ligation and puncture or sham operation. TheAdministration 5 animals are assigned into three equal groups (n=34) according to random number table: sham group, modelgroup, and caspase-3 inhibitor (CI) group. Thirty minutes before CLP, Ac-DEVD-CHO (4 g/g) is injectedsubcutaneously in CI group.

12、 The levels of blood urea nitrogen (BUN) and creatinine (Cr) are determined, andthe concentrations of tumor necrosis factor- (TNF-), interleukins (IL-6 and IL-10) are measured by enzymelinked immunosorbent assay (ELISA), the renal cell apoptosis rate is determined by flow cytometry. The 4-day and 7-

13、day survival rates of three groups of mice are observed 5.MCE has not independently confirmed the accuracy of these methods. They are for reference only.2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Cell Prolif. 2019 Jul 26:e12663. Apoptosis. 2019 Jun 7. Apoptosis. 2019 Apr;24(3-4):31

14、2-325.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Garcia-Calvo M, et al.nhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem. 1998 Dec4;273(49):32608-13.2. Jinglin Wang, et al. A polysaccharide from Lentinus edodes inhibits human colon can

15、cer cell proliferation and suppresses tumor growthin athymic nude mice. Oncotarget. 2017 Jan 3; 8(1): 610-623.3. Junping Zhang, et al. Hypericin-mediated photodynamic therapy induces apoptosis of myoloma SP2/0 cells depended on caspaseactivity in vitro. Cancer Cell Int. 2015; 15: 584. Long-gang He,

16、et al. Sinomenine induces apoptosis in RAW 264.7 cell-derived osteoclasts in vitro via caspase-3 activation. ActaPharmacol Sin. 2014 Feb; 35(2): 203-210.5. Liu LX, et al. The effect of caspase-3 inhibitor on the concentrations of serum inflammatory cytokines in sepsis related acute kidneyinjury induced by peritoneal cavity infection in mice. Zhongguo Wei Zhong

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論